论文部分内容阅读
BACKGROUND:Depression is a common comorbid condition in Alzheimers disease (AD), particularly in the early stages, and the prevalence of depression is higher among people with AD compared to older adults with normal cognition.Comorbidity with depression may increase the risk of cognitive decline, impair a patients function and quality of life.Therefore, understanding the mechanisms is important in order to increase the efficiency of early diagnostics and the selection of optimal treatment strategy for these conditions.Proton magnetic resonance spectroscopy (1H-MRS) is a noninvasive magnetic resonance imaging (MRI) method to measure brain metabolite concentrations, and has been used in clinical studies of major depressive disorder (MDD) and AD.